Zyversa Therapeutics Inc.

09/10/2025 | Press release | Distributed by Public on 09/10/2025 06:14

ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term[...]

Zyversa Therapeutics Inc. published this content on September 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 10, 2025 at 12:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]